A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance

Journal of Psychopharmacology

Volumn 20, Issue 4, 2006, Pages 496-505

  Theunissen, Eef L ^a,b   Jonkman, Lisa M ^b   Kuypers, Kim P C ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Attention; Event related potentials; H1 receptor antagonist; Psychomotor performance; Psychostimulant

Indexed keywords

FEXOFENADINE; PLACEBO;

ADULT; ARTICLE; ATTENTION; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LATENT PERIOD; MALE; NERVE STIMULATION; NEUROPHYSIOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RESPONSE TIME; SINGLE DRUG DOSE; TASK PERFORMANCE; VOLUNTEER; WORKLOAD;

ADULT; ATTENTION; BEHAVIOR; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EVOKED POTENTIALS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; STIMULATION, CHEMICAL; TERFENADINE;

EID: 33745011177     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881105058362     Document Type: Article

References (56)

1. Bergman J, Spealman R D (1988) Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol. J Pharmacol Exp Ther 245: 471-478
2. Bower E A, Moore J L, Moss M, Selby K A, Austin M, Meeves S (2003) The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. Aviat Space Environ Med 74: 145-152
3. Brocke B, Tasche K G, Beauducel A (1996) Biopsychological foundations of extraversion: differential effort reactivity and the differential P300 effect. Personality and Individual Differences 21: 727-738
4. Clarke C H, Nicholson A N (1978) Performance studies with antihistamines. Br J Clin Pharmacol 6: 31-35
5. Conners C K (1992) Conners' Continuous Performance Test computer program user's guide. Multi-Health Systems, Toronto
6. Coull J T (1998) Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol 55: 343-361
7. Dringenberg H C, de Souza-Silva M A, Schwarting R K, Huston J P (1998) Increased levels of extracellular dopamine in neostriarum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch Pharmacol 358: 423-429
8. Duncan-Johnson C C (1981) Young Psychophysiologist Award address, 1980. P300 latency: a new metric of information processing. Psychophysiology 18: 207-215
9. Duncan-Johnson C C, Donchin E (1977) On quantifying surprise: the variation of event-related potentials with subjective probability. Psychophysiology 14: 456-567
10. Falkenstein M, Hoormann J, Hohnsbein J (1999) ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychol (Amst) 101: 267-291
11. Gengo F M (1996) Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress. J Allergy Clin Immunol 98: S319-325
12. Hindmarch I, Shamsi Z (1999) Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy 29: 133-142
13. Hindmarch I, Shamsi Z, Stanley N, Fairweather D B (1999) A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 48: 200-206
14. Houx P J, Jolles J (1993) Age-related decline of psychomotor speed: effects of age, brain health, sex, and education. Percept Mot Skills 76: 195-211
15. Isreal J B, Chesney G L, Wickens C D, Donchin E (1980) P300 and tracking difficulty: evidence for multiple resources in dual-task performance. Psychophysiology 17: 259-273
16. Jex H R, McDonnell J D, Phatak A V (1966) A 'critical' tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR 1-105
17. Jodo E, Kayama Y (1992) Relation of a negative ERP component to response inhibition in a Go/No-go task. Electroencephalogr Clin Neurophysiol 82: 477-482
18. Kok A (1997) Event-related-potential (ERP) reflections of mental resources: a review and synthesis. Biol Psychol 45: 19-56
19. Kok A (2001) On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology 38: 557-577
20. Mangun G R (1995) Neural mechanisms of visual selective attention. Psychophysiology 32: 4-18
21. Mangun G R, Hillyard S A (1990) Electrophysiological studies of visual selective attention in humans. In Scheibel A B, Wechsler A F (eds), Neurobiology of higher cognitive function. Guilford, New York
22. Mangun G R, Hillyard S A (1995) Mechanisms and models of selective attention. In Rugg M D, Coles M G H (eds), Electrophysiology of mind. Event-related brain potentials and cognition. Oxford University Press, Oxford
23. Matsunaga K, Sato T, Shuto H, Tsuruta Y, Suemaru K, Gomita Y, Oishi R (1998) Inhibition of neuronal dopamine uptake by some antiallergic drugs. Eur J Pharmacol 350: 165-169
24. Mattila M J, Kuitunen T, Pletan Y (1992) Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 43: 179-184
25. Mertens R, Polich J (1997) P300 from a single-stimulus paradigm: passive versus active tasks and stimulus modality. Electroencephalogr Clin Neurophysiol 104: 488-497
26. Moskowitz H (1973) Laboratory studies of the effects of alcohol on some variables related to driving. Journal of Safety Research 5: 185-192
27. Moskowitz H, Burns M B (1988) Effects of terfenadine, diphenhydramine, and placebo on skills performance. Cutis 42: 14-18
28. Nicholson A N, Stone B M, Turner C, Mills S L (2000) Antihistamines and aircrew: usefulness of fexofenadine. Aviat Space Environ Med 71: 2-6
29. O'Hanlon J F, Ramaekers J G (1995) Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 50: 234-342
30. Oishi R, Shishido S, Yamori M, Saeki K (1994) Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 349: 140-144
31. Onodera K, Yamatodani A, Watanabe T, Wada H (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42: 685-702
32. Onoe H, Yamatodani A, Watanabe T, Ono K, Mochizuki T, Wada H, Hayaishi O (1992) Prostaglandin E2 and histamine in the posterior hypothalamus. J Sleep Res 1: 166
33. Passalacqua G, Bousquet J, Bachert C, Church M K, Bindsley-Jensen C, Nagy L, Szemere P, Davies R J, Durham S R, Horak F, Kontou-Fili K, Malling H J, van Cauwenberge P, Canonica G W (1996) The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy 51: 666-675
34. Picton T W (1992) The P300 wave of the human event-related potential. J Clin Neurophysiol 9: 456-479
35. Polich J, Kok A (1995) Cognitive and biological determinants of P300: an integrative review. Biol Psychol 41: 103-146
36. Ramaekers J G, O'Hanlon J F (1994) Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 47: 261-266
37. Reinberg A, Levi F, Guillet P, Burke J T, Nicolai A (1978) Chronopharmacological study of antihistamines in man with special references to terfenadine. Eur J Clin Pharmacol 14: 245-252
38. Ridout F, Shamsi Z, Meadows R, Johnson S, Hindmarch I (2003) A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Clin Ther 25: 1518-1538
39. Riedel W J, Ramaekers G, Uiterwijk M M, O'Hanlon J F (1990) Higher doses of terfenadine and loratadine: acute and subchronic effects on psychomotor and actual driving performance. Institute for Drugs, Safety and Behavior, University of Limburg. IGVG 90-12
40. Rombaut N E I, Hindmarch I (1994) Psychometric aspects of antihistamines: a review. Human Psychopharmacology 9: 157-169
41. Rugg M D, Milner A D, Lines C R, Phalp R (1987) Modulation of visual event-related potentials by spatial and non-spatial visual selective attention. Neuropsychologia 25: 85-96
42. Semlitsch H V, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23: 695-703
43. Simons F E (1994) H1-receptor antagonists. Comparative tolerability and safety. Drug Saf 10: 350-380
44. Smulders F T, Kok A, Kenemans J L, Bashore T R (1995) The temporal selectivity of additive factor effects on the reaction process revealed in ERP component latencies. Acta Psychol (Amst) 90: 97-109
45. Snyder S H, Snowman A M (1987) Receptor effects of cetirizine. Ann Allergy 59: 4-8
46. Suzuki T, Mori T, Tsuji M, Nomura M, Misawa M, Onodera K (1999) Evaluation of the histamine H1-antagonist-induced place preference in rats. Jpn J Pharmacol 81: 332-338
47. Taylor M J (2002) Non-spatial attentional effects on P1. Clin Neurophysiol 113: 1903-1908
48. Theunissen E L, Vermeeren A, van Oers A C M, van Maris I, Ramaekers J G (2004) A dose ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clin Exp Allergy 34: 250-258
49. Vermeeren A, O'Hanlon J F (1998) Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 101: 306-311
50. Vermeeren A, Ramaekers J G, O'Hanlon J F (2002) Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J Psychopharmacol (Oxf) 16: 57-64
51. Vuurman E F, Uiterwijk M M, Rosenzweig P, O'Hanlon J F (1994) Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 47: 253-259
52. Vuurman E F P M, Rikken G H, Muntjewerff N D, de Halleux F, Ramaekers J G (2004) Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol 60: 307-313
53. Weiler J M, Bloomfield J R, Woodworth G G, Grant A R, Layton T A, Brown T L, McKenzie D R, Baker T W, Watson G S (2000) Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med 132: 354-363
54. Wickens C, Kramer A, Vanasse L, Donchin E (1983) Performance of concurrent tasks: a psychophysiological analysis of the reciprocity of information-processing resources. Science 221: 1080-1082
55. Wickens C D, Isreal J B, Donchin E (1977) The event-related cortical potential as an index of task workload. In Neal A S, Palased R F (eds), Proceedings of the Human Factors Society 21st annual meeting. Human Factors Society, Santa Monica
56. Willard J, Johnson M, Rosenfeld J P (1994) Interaction of oddball probability and primary task type on P300 in the dual-task paradigm. Biofeedback Self Regul 19: 13-24